Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Solaraze vs Efudix vs cryotherapy in immunocompetent patients with actinic keratoses
2006-000815-24Phase 4Terminated
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- May 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of diclofenac and fluorouracil in actinic keratosis (AK) (3 arms), sponsored by Charité – Universitätsmedizin Berlin. Primary endpoints: Clinical efficacy: percent reduction of lesions at end of treatment, Clinical efficacy: recurrence rates of lesions and 2 more. Started May 2006; status: terminated.
02
Drugs
diclofenacfluorouracil
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on 2006-000815-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000815-24.